Coyote-Dotor Guadalupe, Páez-Franco José C, Canseco-González Daniel, Núñez-Pineda Alejandra, Dorazco-González Alejandro, Fuentes-Noriega Inés, Vilchis-Néstor Alfredo R, Rodríguez-Hernández Joelis, Morales-Morales David, Germán-Acacio Juan Manuel
Red de Apoyo a la Investigación, Coordinación de la Investigación Científica-UNAM, Instituto Nacional de Ciencias Médicas y Nutrición SZ, Ciudad de México 14000, Mexico.
CONACYT-Laboratorio Nacional de Investigación y Servicio Agroalimentario y Forestal, Universidad Autónoma de Chapingo, Texcoco de Mora 56230, Mexico.
Pharmaceutics. 2021 Nov 14;13(11):1926. doi: 10.3390/pharmaceutics13111926.
The mechanochemical synthesis of drug-drug solid forms containing metformin hydrochloride (MET·HCl) and thiazide diuretics hydrochlorothiazide (HTZ) or chlorothiazide (CTZ) is reported. Characterization of these new systems indicates formation of binary eutectic conglomerates, i.e., drug-drug eutectic solids (DDESs). Further analysis by construction of binary diagrams (DSC screening) exhibited the characteristic V-shaped form indicating formation of DDESs in both cases. These new DDESs were further characterized by different techniques, including thermal analysis (DSC), solid state NMR spectroscopy (SSNMR), powder X-ray diffraction (PXRD) and scanning electron microscopy-energy dispersive X-ray spectroscopy analysis (SEM-EDS). In addition, intrinsic dissolution rate experiments and solubility assays were performed. In the case of MET·HCl-HTZ (χ = 0.66), we observed a slight enhancement in the dissolution properties compared with pure HTZ (1.21-fold). The same analysis for the solid forms of MET·HCl-CTZ (χ = 0.33 and 0.5) showed an enhancement in the dissolved amount of CTZ accompanied by a slight improvement in solubility. From these dissolution profiles and saturation solubility studies and by comparing the thermodynamic parameters (ΔH and ΔS) of the pure drugs with these new solid forms, it can be observed that there was a limited modification in these properties, not modifying the free energy of the solution (ΔG) and thus not allowing an improvement in the dissolution and solubility properties of these solid forms.
报道了含盐酸二甲双胍(MET·HCl)与噻嗪类利尿剂氢氯噻嗪(HTZ)或氯噻嗪(CTZ)的药物-药物固体形式的机械化学合成。这些新体系的表征表明形成了二元低共熔聚集体,即药物-药物低共熔固体(DDESs)。通过构建二元相图(DSC筛选)进行的进一步分析显示出特征性的V形,表明在两种情况下均形成了DDESs。这些新的DDESs通过不同技术进一步表征,包括热分析(DSC)、固态核磁共振光谱(SSNMR)、粉末X射线衍射(PXRD)和扫描电子显微镜-能量色散X射线光谱分析(SEM-EDS)。此外,进行了固有溶解速率实验和溶解度测定。对于MET·HCl-HTZ(χ = 0.66),与纯HTZ相比,我们观察到溶解性能略有提高(1.21倍)。对MET·HCl-CTZ(χ = 0.33和0.5)固体形式的相同分析表明,CTZ的溶解量增加,同时溶解度略有改善。从这些溶解曲线和饱和溶解度研究以及通过将纯药物与这些新固体形式的热力学参数(ΔH和ΔS)进行比较,可以观察到这些性质有有限的改变,未改变溶液的自由能(ΔG),因此不允许改善这些固体形式的溶解和溶解度性质。